199 related articles for article (PubMed ID: 21945860)
1. A challenging drug development process in the era of personalized medicine.
Jørgensen JT
Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
[TBL] [Abstract][Full Text] [Related]
2. Systems biology in drug discovery and development.
Berg EL
Drug Discov Today; 2014 Feb; 19(2):113-25. PubMed ID: 24120892
[TBL] [Abstract][Full Text] [Related]
3. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine: changing the paradigm of drug development.
Couch RD; Mott BT
Methods Mol Biol; 2012; 823():367-78. PubMed ID: 22081358
[TBL] [Abstract][Full Text] [Related]
5. Nanobiotechnology and personalized medicine.
Jain KK
Prog Mol Biol Transl Sci; 2011; 104():325-54. PubMed ID: 22093223
[TBL] [Abstract][Full Text] [Related]
6. Network medicine: finding the links to personalized therapy.
Chen JY; Piquette-Miller M; Smith BP
Clin Pharmacol Ther; 2013 Dec; 94(6):613-6. PubMed ID: 24241633
[TBL] [Abstract][Full Text] [Related]
7. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
8. Overview of personalized medicine in the disease genomic era.
Hong KW; Oh B
BMB Rep; 2010 Oct; 43(10):643-8. PubMed ID: 21034525
[TBL] [Abstract][Full Text] [Related]
9. What is next for small-molecule drug discovery?
Doweyko AM; Doweyko LM
Future Med Chem; 2009 Sep; 1(6):1029-36. PubMed ID: 21425992
[TBL] [Abstract][Full Text] [Related]
10. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
11. Progress towards personalized medicine.
Bates S
Drug Discov Today; 2010 Feb; 15(3-4):115-20. PubMed ID: 19914397
[TBL] [Abstract][Full Text] [Related]
12. Network-based drugs and biomarkers.
Erler JT; Linding R
J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.
Zineh I; Huang SM
Biomark Med; 2011 Dec; 5(6):705-13. PubMed ID: 22103607
[TBL] [Abstract][Full Text] [Related]
14. Genomics and personalized medicine.
Sadee W
Int J Pharm; 2011 Aug; 415(1-2):2-4. PubMed ID: 21539903
[TBL] [Abstract][Full Text] [Related]
15. The application of next-generation sequencing technologies to drug discovery and development.
Woollard PM; Mehta NA; Vamathevan JJ; Van Horn S; Bonde BK; Dow DJ
Drug Discov Today; 2011 Jun; 16(11-12):512-9. PubMed ID: 21440664
[TBL] [Abstract][Full Text] [Related]
16. The importance of drug-target residence time.
Zhang R; Monsma F
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
[TBL] [Abstract][Full Text] [Related]
17. Data integration and systems biology approaches for biomarker discovery: challenges and opportunities for multiple sclerosis.
Villoslada P; Baranzini S
J Neuroimmunol; 2012 Jul; 248(1-2):58-65. PubMed ID: 22281286
[TBL] [Abstract][Full Text] [Related]
18. Translational proteomics: what can you do for true patients?
Belda-Iniesta C; de Castro J; Perona R
J Proteome Res; 2011 Jan; 10(1):101-4. PubMed ID: 20977278
[TBL] [Abstract][Full Text] [Related]
19. Network biology as a new approach to drug discovery.
Lowe JA; Jones P; Wilson DM
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):524-6. PubMed ID: 20812143
[TBL] [Abstract][Full Text] [Related]
20. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]